UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study

International journal of clinical pharmacology and therapeutics, 2024-10, Vol.62 (10), p.448-459

2024

Volltextzugriff (PDF)

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach

Journal of thrombosis and haemostasis, 2021-09, Vol.19 (9), p.2161-2170

2021

Volltextzugriff (PDF)

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Intensive care medicine, 2018-04, Vol.44 (4), p.438-448

2018

Volltextzugriff (PDF)

Polyvalent Immunoglobulin Preparations Inhibit Pneumolysin-Induced Platelet Destruction

Thrombosis and haemostasis, 2022-07, Vol.122 (7), p.1147-1158

2022

Volltextzugriff (PDF)

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations

Stem cells and development, 2014-04, Vol.23 (7), p.755-766

2014

Volltextzugriff (PDF)

The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial

Critical care (London, England), 2023-11, Vol.27 (1), p.1-436, Article 436

2023

Volltextzugriff (PDF)

Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models

Pharmaceutical research, 2018-06, Vol.35 (6), p.118-10, Article 118

2018

Volltextzugriff (PDF)

Long‐term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.467-477

2020

Volltextzugriff (PDF)

Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial

Fetal diagnosis and therapy, 2021-10, Vol.48 (8), p.611-623

2021

Volltextzugriff (PDF)

Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations

Annals of Transplantation, 2016-09, Vol.21, p.558-564

2016

Volltextzugriff (PDF)

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate

PloS one, 2018-04, Vol.13 (4), p.e0195823-e0195823

2018

Volltextzugriff (PDF)

Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells

Frontiers in immunology, 2016-01, Vol.7, p.11-11

2016

Volltextzugriff (PDF)

Specific gene delivery to liver sinusoidal and artery endothelial cells

Blood, 2013-09, Vol.122 (12), p.2030-2038

2013

Volltextzugriff (PDF)

Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)

European journal of medical research, 2024-08, Vol.29 (1), p.418-15, Article 418

2024

Volltextzugriff (PDF)

Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro

Blood advances, 2020-12, Vol.4 (24), p.6315-6326

2020

Volltextzugriff (PDF)

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice

Blood, 2012-01, Vol.119 (2), p.602-611

2012

Volltextzugriff (PDF)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin

Biomedicines, 2021-12, Vol.9 (12), p.1828

2021

Volltextzugriff (PDF)

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years

Hamostaseologie, 2019-11, Vol.39 (4), p.360-367

2019

Volltextzugriff (PDF)

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

Immunology and cell biology, 2015-04, Vol.93 (4), p.396-405

2015

Volltextzugriff (PDF)

Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A

PloS one, 2012-09, Vol.7 (9), p.e44505-e44505

2012

Volltextzugriff (PDF)

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

Blood, 2012-11, Vol.120 (21), p.1248-1248

2012

Volltextzugriff (PDF)

The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System

Biomedicines, 2021-07, Vol.9 (7), p.817

2021

Volltextzugriff (PDF)

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Blood, 2004-01, Vol.103 (1), p.85-92

2004

Volltextzugriff (PDF)

Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX

Human gene therapy, 2011-01, Vol.22 (1), p.101-106

2011

Volltextzugriff (PDF)

Sufficient blood, safe blood: can we have both?

BMC medicine, 2012-03, Vol.10 (1), p.29-29, Article 29

2012

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(43)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Polyvalent Immunoglobulin Preparations Inhibit Pneumolysin-Induced Platelet Destruction

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations

The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial

Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models

Long‐term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A

Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial

Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations

Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate

Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells

Specific gene delivery to liver sinusoidal and artery endothelial cells

Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)

Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX

Sufficient blood, safe blood: can we have both?

Suchergebnisse filtern